The American Journal of Managed Care50m
Uniting to Support Patients With Cancer Beyond Treatment
Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center ...
The American Journal of Managed Care9h
Delandistrogene Moxeparvovec Fails to Meet Primary End Point in Phase 3 Study
Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...
The American Journal of Managed Care18h
From Benefit Status to Transplants, CV Disparities Prove Tough to Tackle
Posters presented at the American Heart Association Scientific Sessions included results that show how persistent disparities ...
The American Journal of Managed Care22h
For Obesity and HFpEF, Tirzepatide Cuts Risk of CV Death or Worsening HF by 38%
Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...